Substance use and psychiatric comorbidities among medical inpatients: associations with length of stay, health-related quality of life, and functioning, with consideration for gender

Little is known about the impact of substance use and psychiatric comorbidities on the management and outcomes of medical inpatients. This study explores the influence of psychiatric comorbidities, and substance use (tobacco, alcohol, and cannabis) on the length of hospital stay (LOS), Health-Relate...

ver descrição completa

Detalhes bibliográficos
Autores: Pons-Cabrera, Maria Teresa, Caballería Lamora, Elsa, Navarro Cortes, Lourdes, Borràs, Roger, Barrio Giménez, Pablo, Manthey, Jakob, Batalla Cases, Albert, Oliveras, Clara, Sagué Vilavella, Maria, Balcells Oliveró, Maria Mercè, Pintor Pérez, Luis, López Pelayo, Hugo
Formato: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2025
País:España
Recursos:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/223051
Acesso em linha:https://hdl.handle.net/2445/223051
Access Level:acceso abierto
Palavra-chave:Comorbiditat
Psiquiatria
Abús de substàncies
Comorbidity
Psychiatry
Substance abuse
Descrição
Resumo:Little is known about the impact of substance use and psychiatric comorbidities on the management and outcomes of medical inpatients. This study explores the influence of psychiatric comorbidities, and substance use (tobacco, alcohol, and cannabis) on the length of hospital stay (LOS), Health-Related Quality of Life (HRQoL), and functioning in 800 medical inpatients at a high-complexity academic hospital. Multivariate analyses demonstrated that psychiatric comorbidities were associated with reduced HRQoL (beta = -0.050, p-value = 0.017), and impaired functioning (beta = 3.4, p-value

Registos relacionados